medigraphic.com
ISSN 2594-1526 (Electronic)
Antes Revista del Instituto Nacional de Enfermedades Respiratorias

 Ver anteriores al 2010

2015, Number 2

<< Back Next >>

Neumol Cir Torax 2015; 74 (2)

Comorbidities, sleep quality and quality of life in patients with lung cancer

Torre-Bouscoulet L, Arrieta-Rodríguez O, Pérez-Padilla R, Guzmán-Barragán A, Reyes-Zúñiga M, Martínez-Briseño D, Fernández-Plata R, García-Sancho C

Language: Spanish
References: 27
Page: 87-94
PDF size: 209.82 Kb.


ABSTRACT

Background: Patients with advanced lung cancer show medical conditions and comorbidities which decreases the sleep quality and quality of life that could affect the oncological treatment response and the prognosis of patients. Objective: The proposal of this study was to investigate, in patients with advanced lung cancer, the prevalence of medical conditions and comorbidities that could be reverted before radiotherapy or chemotherapy treatment. Material and methods: Study design: baseline assessment of consecutive patients with diagnosed of non-small lung cancer stages III-A and III-B. To investigate the comorbidities we use PLATINO questionnaire (www.platino-alat.org/docs/cuestionario_ platino_ mexico.pdf). We applied also dyspnea scale MRC, the Pittsburgh sleep quality index (PSQI) and EuroQL. Lung function tests were spirometry, carbon monoxide diffusing capacity (DLCO) and gasometry (ATS/ERS 2005). PSQI and EuroQL scales were analyzed according authors criteria. Results: 46 patients were recruited; a) 32.6% of patients have a comorbid condition and 13.1% dyspnea; b) COPD prevalence was of 39.1% and 16.7% show hypoxemia; c) 50% reported a poor quality of sleep; d) the mean of quality of life score was high (0.848 [SE ± 0.185]); 45.7% refer pain and 19.6% anxiety and depression symptoms; e) sleep quality was significantly associated with pain and anxiety and depression symptoms. Conclusions: There are comorbidities and medical conditions in advanced lung cancer patients that could be treated before the radio and chemotherapy to improve the prognosis.


REFERENCES

  1. Wang JW, Gong XH, Ding N, et al. The influence of comorbid chronic diseases and physical activity on quality of life in lung cancer survivors. Support Care Cancer 2015;23(5):1383-1389. doi: 10.1007/s00520-014-2494-7.

  2. Aarts MJ, Aerts JG, van den Borne BE, Biesma B, Lemmens VE, Kloover JS. Comorbidity in patients with small-cell lung cancer: trends and prognostic impact. Clin Lung Cancer 2015;16(4):282-291. doi: 10.1016/ j.cllc.2014.12.003.

  3. Menezes AM, Victora CG, Perez-Padilla R; PLATINO Team. The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. BMC Med Res Methodol 2004;4:15.

  4. López-Varela MV, Montes-de Oca M, Halbert R, et al. Comorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO study. Arch Bronconeumol 2013;49(11):468-474. doi: 10.1016/j.arbres.2013.05.003.

  5. Medical Research Council. Committee on research into chronic bronchitis: Instruction for use on the questionnaire on respiratory symptoms. Devon: W J Holman; 1966.

  6. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Research 1989;28(2):193-213.

  7. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 2005;43(3):203-220.

  8. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26(2):319-338.

  9. Stata Technical Support. Citing Stata software, documentation, and FAQs; Date November 1999; updated June 2013.

  10. Akgün KM, Crothers K, Pisani M. Epidemiology and management of common pulmonary diseases in older persons. J Gerontol A Biol Sci Med Sci 2012;67(3):276-291. doi: 10.1093/gerona/glr251.

  11. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012;379(9823):1341-1351. doi: 10.1016/S0140-6736(11)60968-9.

  12. Loganathan RS, Stover DE, Shi W, Venkatraman E. Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest 2006;129(5):1305-1312.

  13. Maldonado F, Bartholmai BJ, Swensen SJ, Midthun DE, Decker PA, Jett JR. Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis. Chest 2010;138(6):1295-1302. doi: 10.1378/chest.09-2567.

  14. Rivas-Perez H, Nana-Sinkam P. Integrating pulmonary rehabilitation into the multidisciplinary management of lung cancer: A review. Respir Med 2015;109(4):437-442. doi:10.1016/j.rmed.2015.01.001.

  15. Barreto SS, McClean PA, Szalai JP, Zamel N. Reduction of lung diffusion for carbon monoxide in patients with lung carcinoma. Chest 1993;103(4):1142-1146.

  16. Ekström MP, Wagner P, Ström KE. Trends in cause-specific mortality in oxygen-dependent chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011;183(8):1032-1036. doi: 10.1164/rccm.201010-1704OC.

  17. Wilcock A, England R, El Khoury B, et al. The prevalence of nocturnal hypoxemia in advanced cancer. J Pain Symptom Manage 2008;36(4):351-357. doi: 10.1016/j.jpainsymman.2007.11.007.

  18. Dean GE, Redeker NS, Wang YJ, et al. Sleep, mood, and quality of life in patients receiving treatment for lung cancer. Oncol Nurs Forum 2013;40(5):441-451. doi: 10.1188/13.ONF.441-451.

  19. Cheville AL, Kollasch J, Vandenberg J, et al. A home-based exercise program to improve function, fatigue, and sleep quality in patients with Stage IV lung and colorectal cancer: a randomized controlled trial. J Pain Symptom Manage 2013;45(5):811-821. doi: 10.1016/j.jpainsymman.2012.05.006.

  20. Delgado-Guay M, Yennurajalingam S, Parsons H, Palmer JL, Bruera E. Association between self-reported sleep disturbance and other symptoms in patients with advanced cancer. J Pain Symptom Manage 2011;41(5):819-827. doi: 10.1016/j.jpainsymman.2010.07.015.

  21. van Onselen C, Dunn LB, Lee K, et al. Relationship between mood disturbance and sleep quality in oncology outpatients at the initiation of radiation therapy. Eur J Oncol Nurs 2010;14(5):373-379. doi: 10.1016/j.ejon.2009.12.002.

  22. Dean GE, Abu-Sabbah E, Yingrengreung S, et al. Sleeping with the enemy: sleep and quality of life in patients with lung cancer. Cancer Nurs 2015;38(1):60-70. doi: 10.1097/NCC.0000000000000128.

  23. Quinten C, Martinelli F, Coens C, et al; Patient Reported Outcomes and Behavioral Evidence (PROBE) and the European Organization for Research and Treatment of Cancer (EORTC) Clinical Groups. A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer 2014;120(2):302-311. doi: 10.1002/cncr.28382.

  24. Liao YC, Shun SC, Liao WY, Yu CJ, Yang PC, Lai YH. Quality of life and related factors in patients with newly diagnosed advanced lung cancer: a longitudinal study. Oncol Nurs Forum 2014;41(2):E44-55. doi: 10.1188/14.ONF.E44-E55.

  25. Baker F, Haffer SC, Denniston M. Health-related quality of life of cancer and non cancer patients in Medicare managed care. Cancer 2003;97(3):674-681.

  26. Granger CL, McDonald CF, Irving L, et al. Low physical activity levels and functional decline in individuals with lung cancer. Lung Cancer 2014;83(2):292-299. doi: 10.1016/j.lungcan.2013.11.014.

  27. Akechi T, Okamura H, Nishiwaki Y, Uchitomi Y. Predictive factors for suicidal ideation in patients with unresectable lung carcinoma. Cancer 2002;95(5):1085-1093.




2020     |     www.medigraphic.com